BFEC
ASTH icon

Benjamin F. Edwards & Company’s Astrana Health ASTH Stock Holding History

Benjamin F. Edwards & Company’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-150
Closed -$14K – 1779
2021
Q3 		$14K Buy
+150
New +$12.8K ﹤0.01% 1320

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Benjamin F. Edwards & Company's ASTH Position: Q4 2021 in Review

Benjamin F. Edwards & Company sold out of Astrana Health (ASTH) in Q4 2021, closing a stake of 150 shares — an estimated $14K sold.

Benjamin F. Edwards & Company first reported a position in ASTH in Q3 2021 and held it in 1 quarter. The position peaked at $14K in Q3 2021. 149 funds tracked by Wall St. Rank hold ASTH as of Q4 2021.

  • Benjamin F. Edwards & Company reported no remaining Astrana Health position as of Q4 2021 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 150 Astrana Health shares in Q4 2021, an estimated $14K.
  • Benjamin F. Edwards & Company first reported a position in Astrana Health in Q3 2021 and held it in 1 quarter.
  • Benjamin F. Edwards & Company's Astrana Health position peaked at $14K in Q3 2021.
  • 149 funds tracked by Wall St. Rank held Astrana Health as of Q4 2021.

Based on Benjamin F. Edwards & Company's 13F filing for Q4 2021, filed 7 Feb 2022.